Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Graves

Showing results (131-140 of 771) with videos related to

Pageof 78
Sort By:
The International Journal of Biochemistry|January 1, 1988
Characterization of the interaction of ophiobolin A and calmodulinP C Leung, L M Graves, C L Tipton
The AAPS Journal|June 13, 2025
Dose Optimization of ClpP Agonists Using an In Vitro Microfluidic Perfusion Platform and In Silico Pharmacokinetic-Pharmacodynamic ModelingRonald W Bucher, Lee M Graves, Derek W Bartlett
Public Health Nursing (Boston, Mass.)|April 19, 2024
The four stages of neighborhood trust: Classic grounded theoryShawna Beese, Janessa M Graves, Julie Postma, et al.
The Annals of Pharmacotherapy|May 1, 1995
Predicting unbound phenytoin concentrations in patients receiving valproic acid: a comparison of two prediction methodsJ M Kerrick, D L Wolff, N M Graves
Thrombosis Research|December 1, 1975
Von Willebrand factor activity in normal subjects: sex difference and variabilityK E Sarji, J M Graves, J A Colwell
Epilepsy Research. Supplement|January 1, 1988
Compliant populations: variability in serum concentrationsN M Graves, G B Holmes, I E Leppik
Molecular Pharmacology|July 16, 2005
Activation of mitogen-activated protein kinases by peroxisome proliferator-activated receptor ligands: an example of nongenomic signalingOlivia S Gardner, Brian J Dewar, Lee M Graves
American Journal of Public Health|August 14, 2015
Health Care Costs 1 Year After Pediatric Traumatic Brain InjuryJanessa M Graves, Frederick P Rivara, Monica S Vavilala
Journal of Palliative Medicine|April 30, 2005
Management of seizures in brain tumor patients at the end of lifeH G Krouwer, J L Pallagi, N M Graves
Current Opinion in Chemical Biology|June 9, 2005
MAPK kinase kinases (MKKKs) as a target class for small-molecule inhibition to modulate signaling networks and gene expressionGary L Johnson, Henrik G Dohlman, Lee M Graves
Pageof 78

Showing results (131-140 of 771) with videos related to

Sort By:
Pageof 78
The International Journal of Biochemistry|January 1, 1988
Characterization of the interaction of ophiobolin A and calmodulinP C Leung, L M Graves, C L Tipton
The AAPS Journal|June 13, 2025
Dose Optimization of ClpP Agonists Using an In Vitro Microfluidic Perfusion Platform and In Silico Pharmacokinetic-Pharmacodynamic ModelingRonald W Bucher, Lee M Graves, Derek W Bartlett
Public Health Nursing (Boston, Mass.)|April 19, 2024
The four stages of neighborhood trust: Classic grounded theoryShawna Beese, Janessa M Graves, Julie Postma, et al.
The Annals of Pharmacotherapy|May 1, 1995
Predicting unbound phenytoin concentrations in patients receiving valproic acid: a comparison of two prediction methodsJ M Kerrick, D L Wolff, N M Graves
Thrombosis Research|December 1, 1975
Von Willebrand factor activity in normal subjects: sex difference and variabilityK E Sarji, J M Graves, J A Colwell
Epilepsy Research. Supplement|January 1, 1988
Compliant populations: variability in serum concentrationsN M Graves, G B Holmes, I E Leppik
Molecular Pharmacology|July 16, 2005
Activation of mitogen-activated protein kinases by peroxisome proliferator-activated receptor ligands: an example of nongenomic signalingOlivia S Gardner, Brian J Dewar, Lee M Graves
American Journal of Public Health|August 14, 2015
Health Care Costs 1 Year After Pediatric Traumatic Brain InjuryJanessa M Graves, Frederick P Rivara, Monica S Vavilala
Journal of Palliative Medicine|April 30, 2005
Management of seizures in brain tumor patients at the end of lifeH G Krouwer, J L Pallagi, N M Graves
Current Opinion in Chemical Biology|June 9, 2005
MAPK kinase kinases (MKKKs) as a target class for small-molecule inhibition to modulate signaling networks and gene expressionGary L Johnson, Henrik G Dohlman, Lee M Graves
Pageof 78